| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 15 |
| 1 | CARBOPLATIN | 9 |
| 2 | PACLITAXEL | 9 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 9 |
| 4 | CISPLATIN | 8 |
| 5 | METHOTREXATE SODIUM | 8 |
| 6 | METHYLPREDNISOLONE | 8 |
| 7 | PANTOPRAZOLE | 8 |
| 8 | RITUXIMAB | 8 |
| 9 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REVUMENIB | 2 | 0.0019 |
| 1 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 2 | CAPLACIZUMAB | 3 | 0.0017 |
| 3 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| 4 | DAPRODUSTAT | 2 | 0.0010 |
| 5 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 6 | DROPERIDOL | 1 | 0.0006 |
| 7 | SALICYLIC ACID 12% | 1 | 0.0005 |
| 8 | ASTRINGENT | 1 | 0.0005 |
| 9 | LIQUID CORN AND CALLUS REMOVER | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 1 | Benzothiazole [EPC] | 1 | 0.0004 |
| 2 | Sulfone [EPC] | 4 | 0.0004 |
| 3 | Phosphate Binder [EPC] | 1 | 0.0003 |
| 4 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 7 | Bile Acid Sequestrant [EPC] | 2 | 0.0002 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |